The Asahi Enterprise EGM will be held on October 30, 2026, at 12:15 p.m. IST, following approval by the company's board on October 3, according to a BSE filing. Asahi Enterprise Limited, formerly known as Global Longlife Hospital and Research Limited, will conduct the meeting through video conferencing or other audio-visual means.

This will be the company's first extraordinary general meeting for FY 2026-27. The filing says the meeting will seek members' approval for an issuance. However, the supplied board outcome does not specify the type of securities, size, price or other terms of that issuance.

The disclosure identifies the company under BSE scrip code 543520 and ISIN INE0J2K01014, linking the Asahi Enterprise name with the former Global Longlife Hospital and Research identity.

Board approves notice and voting arrangements

The directors adopted the EGM notice and authorised its issuance. The company said it would submit a copy to the exchange once the notice is dispatched to shareholders through email addresses registered with the company or depositories.

The board also approved the following arrangements for the proposed resolutions:

  • Appointed National Securities Depository Limited (NSDL) as the remote e-voting agency.
  • Appointed M/s Insiya Nalawala & Associates, Company Secretary, as scrutinizer to oversee the remote e-voting process in a fair and transparent manner.
  • Approved the EGM schedule covering the remote e-voting cut-off date and the voting start and end dates.

The supplied outcome does not list the specific cut-off date or the opening and closing dates for remote voting.

EGM notice to be hosted online

The company said the EGM notice would also be available on its website, www.globalhospital.co.in. That notice is separate from the board outcome disclosed to BSE.

The October 3 board meeting began at 2:15 p.m. and concluded at 3:30 p.m. The directors also approved other business included in the circulated agenda, without detailing those items in the supplied disclosure.

Managing Director Dhruv Jani signed the filing, which was submitted under Regulation 30 of the SEBI Listing Regulations. The company's registered office is in Ahmedabad, Gujarat.